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DNA damage triggers disruption of telomeric silencing and
Mec1p-dependent relocation of Sir3p
Andrew D. McAinsh*, Suzanna Scott-Drew†, James A.H. Murray†
and Stephen P. Jackson*
In eukaryotic cells, surveillance mechanisms detect and
respond to DNA damage by triggering cell-cycle arrest
and inducing the expression of DNA-repair genes [1].
In budding yeast, a single DNA double-strand break
(DSB) is sufficient to trigger cell-cycle arrest [2]. One
highly conserved pathway for repairing DNA DSBs is
DNA non-homologous end-joining (NHEJ), which
depends on the DNA end-binding protein Ku [3]. NHEJ
also requires the SIR2, SIR3 and SIR4 gene products
[4,5], which are responsible for silencing at telomeres
and the mating-type loci [6]. Because of the link
between NHEJ and the Sir proteins, we investigated
whether DNA damage influences telomeric silencing.
We found that DNA damage triggers the reversible loss
of telomeric silencing and relocation of Sir3p from
telomeres. Complete Sir3p relocation was triggered by
a single DNA DSB, suggesting that the signal is
amplified. Consistent with this idea, Sir3p relocation
depended on the DNA damage-signalling components
Ddc1p and Mec1p. Thus, signalling of DNA damage may
release Sir3p from telomeres and permit its subsequent
association with other nuclear subdomains to regulate
transcription, participate in DNA repair and/or enhance
genomic stability by other mechanisms.
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Results and discussion
DNA damage triggers disruption of telomeric silencing
To determine whether DNA damage disrupts telomeric
silencing in S. cerevisiae, we used strain YP4 (TEL::URA3),
which contains the URA3 gene adjacent to the telomere of
chromosome VII-L. In this strain, the proportion of cells that
are resistant to 5-fluoro-orotic acid (5-FOA), which is toxic to
cells expressing URA3, indicates the level of silencing at the
telomere. To test the effects of DNA damage on telomeric
silencing, we used the radiomimetic drug bleomycin, which
generates DNA DSBs and other forms of DNA damage [7].
Serial dilutions of TEL::URA3 and its isogenic wild-type
strain, W303, were spotted onto synthetic complete (SC)
medium containing or lacking 20 µg/ml bleomycin, in either
the presence or the absence of 5-FOA (Figure 1a).
As expected, a control strain disrupted in SIR3 (∆sir3) did
not grow in the presence of 5-FOA because the telomeric
URA3 was completely derepressed (Figure 1a), and a
rad52 mutant strain, defective in homologous recombina-
tion (the main DSB repair pathway in yeast), grew well in
the absence but not in the presence of bleomycin (data
not shown). Growth of none of the strains was impaired
markedly by the addition of bleomycin alone, and the
presence of 5-FOA alone had no significant effect on the
growth of the wild-type strain (Figure 1a). The addition of
5-FOA alone reduced the growth rate of the TEL::URA3
strain somewhat (Figure 1a), although the plating effi-
ciency and viability of TEL::URA3 was not significantly
impaired. This suggests that the TEL::URA3 strain
expresses URA3 to some extent even under normal growth
conditions. Whereas the combination of 5-FOA and
bleomycin had only a minor deleterious effect on the
growth of the wild-type strain, the presence of these two
agents reduced growth of TEL::URA3 dramatically. W303
contains a mutation in RAD5 (rad5-535), which affects the
relative use of the homologous recombination and NHEJ
pathways [8]. To control for the rad5 mutation in W303,
we repeated the experiments in strains that are RAD5+,
with essentially identical results (data not shown). These
data demonstrate that telomeric silencing is disrupted
when DSBs are induced by bleomycin.
Disruption of telomeric silencing is reversible
To determine whether the derepression of telomeric
silencing is reversible, we assayed the expression of an
ADE2 reporter gene that was integrated adjacent to the
telomeric repeats of chromosome VII-L (TEL::ADE2).
When this strain is plated onto medium (YPD) containing
minimal adenine, expression of ADE2 results in white
colonies, whereas repression of the ADE2 gene produces
red/pink colonies. Initially, we picked a single red colony
and re-streaked it onto medium lacking or containing
10 µg/ml bleomycin. The colony colour remained red in
the absence of bleomycin, whereas predominantly white
colonies formed on bleomycin-containing plates
(Figure 1b, upper panels). To control for any effects of
bleomycin on pigment accumulation, an ade2 mutant
strain was included. This strain remained red in the pres-
ence or absence of bleomycin (Figure 1b, lower panels).
These data confirm our initial finding that bleomycin
treatment results in expression of telomeric reporter
genes. Next, we picked a white colony from the
bleomycin plate and re-streaked it onto YPD (with no
bleomycin) and observed that the majority of colonies
switched back to the repressed, red state (Figure 1b).
Thus, the disruption of telomeric silencing by bleomycin
is reversible.
Sir3p relocates upon induction of DNA damage
One explanation for the above results is that the Sir pro-
teins dissociate from the telomeric DNA upon bleomycin
treatment. We tested this possibility using an affinity-
purified antibody and indirect immunofluorescence
microscopy to visualise Sir3p localisation. As shown previ-
ously for diploid yeast strains [9], Sir3p was localised in a
few concentrated foci predominantly at the nuclear
periphery (Figure 2a,e). In a strain disrupted for SIR3,
no Sir3p immunofluorescence signal was detected,
demonstrating the specificity of the anti-Sir3p antibodies
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Figure 1
Telomeric silencing is reversibly disrupted by bleomycin treatment.
(a) Telomeric silencing was assayed by the ability of strains tagged
with the URA3 gene inserted proximal to the telomere of chromosome
VII-L to grow in the presence of 5-FOA. Growth of a wild-type (WT)
ura3 strain (W303; rows 3,6) was compared with growth of an
isogenic strain, YP4, which has a URA3-tagged telomere (TEL::URA3;
rows 2,5). Growth was assessed in the presence or absence of
5-FOA, and in the absence or presence of 20 µg/ml bleomycin, as
indicated. A SIR3-deleted strain, UCC3, with a URA3-tagged
telomere (TEL::URA3 ∆sir3; rows 1,4) was included as a control.
Each row consists of 10-fold serial dilutions. (b) Silencing was
assayed by monitoring the colony colour of strain TEL::ADE2 in which
the ADE2 gene was inserted proximal to the telomere of chromosome
VII-L. A single red colony (with silenced ADE2) from a YPD plate was
re-streaked onto a YPD plate (i) lacking or (ii) containing bleomycin.
(iii) A single white colony from the bleomycin plate was then re-
streaked onto a YPD plate lacking bleomycin. The lower two panels
compare the colony colour of TEL::ADE2 with an ade2 mutant strain
either in the presence (right panel) or absence (left panel) of
bleomycin. All plates were incubated under identical conditions for
equal amounts of time.
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Figure 2
Sir3p relocates after bleomycin-induced DNA damage. (a–h) Wild-
type (WT; W303) cells from untreated or bleomycin (20 µg/ml)-treated
cultures. (a,b) Staining with anti-Sir3p antibody and detection with
fluorescein isothiocyanate (FITC)-conjugated secondary antibody.
(c,d) The same cells in (a,b) but stained with the DNA dye 4′,6-
diamidino-2-phenylindole (DAPI). (e,f) High-magnification view of Sir3p
localisation in a typical cell from each population. (g,h) Untreated and
bleomycin-treated cells stained with anti-Rep1p antibodies and
detected with FITC-conjugated secondary antibody. (i–k) Cells of the
sir3 mutant (UCC3) stained with (i) anti-Sir3p antibody, (j) DAPI or
(k) anti-tubulin antibody. (l) Western blotting using anti-Sir3p antibody
was performed with equal amounts of whole-cell extract from untreated
or bleomycin (20 µg/ml)-treated W303 cultures, or extract from
untreated sir3 mutant (UCC3) cells (upper panel). The lower panel
shows western blotting using anti-tubulin antibody as a loading control.
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(Figure 2i; see also western blot in Figure 2l). In cells
damaged with bleomycin, the discrete peripheral foci
seen in W303 were lost and, instead, Sir3p was distrib-
uted diffusely throughout the nuclei (Figure 2b,f).
Western blotting demonstrated that the increase in
immunofluorescence following bleomycin treatment was
not due to increased levels of Sir3p (Figure 2l). Although
changes in epitope accessibility cannot be ruled out,
these data suggest that Sir3p relocates following
bleomycin treatment. Relocation of Sir3p was not
restricted to cells that were arrested at G2/M phase fol-
lowing bleomycin treatment. In addition, arrest of W303
cells in G1 phase with α-factor did not trigger relocation
of Sir3p (data not shown). These data suggest that reloca-
tion of Sir3p is not due to cell-cycle arrest/disruption but
is part of a DNA-damage response. Furthermore, treat-
ment with bleomycin does not simply lead to disruption
of nuclear architecture, because this agent did not alter
the localisation of the 2µ-circle-associated factor Rep1p
which, in untreated cells, is in foci that differ from the
Sir3p foci (Figure 2g,h; [10] and data not shown). 
Sir3p relocation and disruption of telomeric silencing are
induced by a single chromosomal DNA DSB
To investigate further the potential involvement of
DNA DSBs in inducing Sir3p relocation and disruption
of telomeric silencing, we tested the effects of inducing
a single genomic DSB with the HO endonuclease. Thus,
W303 cells were transformed with a plasmid that
expressed HO endonuclease under the control of the
GAL1-10 promoter (pGAL:HO), or with an empty vector
(pRS416). When grown in the presence of galactose, the
HO endonuclease is continually expressed, resulting in
repeated cleavage of a single DNA DSB at the MAT
locus. Strikingly, as shown in Figure 3a (right panel),
induction of HO endonuclease triggered the relocation
of Sir3p, leading to its diffuse staining throughout the
nucleus. In contrast, Sir3p remained in discrete periph-
eral foci in cells carrying the empty vector that were
grown in the presence of galactose (Figure 3a; left
panel). Western blotting demonstrated that Sir3p levels
were unaffected by expression of HO endonuclease
(Figure 3b). Next, we determined whether induction of
HO endonuclease disrupts telomeric silencing. To do
this, the TEL::ADE2 strain was transformed with an
empty vector, or with the plasmid expressing HO
endonuclease, and a single colony of each strain was
streaked onto galactose medium containing minimal
adenine to assess colony colour and, thereby, telomeric
silencing. As shown in Figure 3c, cells expressing the
HO endonuclease were predominantly white, whereas
control cells carrying the empty vector were red/pink.
Together with the Sir3p immunofluorescence studies,
these data reveal that a single genomic DNA DSB is suf-
ficient to induce Sir3p relocation and disruption of
telomeric silencing.
Relocation of Sir3p requires DNA damage checkpoint
components
The above results suggest the involvement of a DNA
damage-signalling pathway. We therefore examined the
effects of bleomycin on strains mutated in genes involved
in DNA-damage signalling. First, we studied a strain in
which MEC1 was disrupted. In contrast to wild-type yeast,
treatment of the mec1 strain with bleomycin had no effect
on the location of Sir3p in foci at the nuclear periphery
(Figure 4). These results indicate that functional Mec1p is
essential for the effective relocation of Sir3p following
DNA damage. We also examined Sir3p location before
and after bleomycin treatment in cells disrupted in TEL1,
a gene that has high homology to MEC1, and functions in
DNA-damage signalling in a partially redundant manner
with MEC1 [11]. Following bleomycin treatment, tel1
mutant cells relocated Sir3p (Figure 4), indicating that
Tel1p is not essential for Sir3p relocation. Next, we exam-
ined a strain disrupted in the RAD53 gene, whose product
is a protein kinase that functions downstream of Mec1p
[12]. Although analysis is difficult in the rad53 mutant
because there is some Sir3p mislocalisation even in the
absence of bleomycin, it was apparent that Sir3p became
more diffuse in the nucleus of this strain after bleomycin
exposure (Figure 4). Thus, Rad53p is not essential for
Sir3p relocation after bleomycin treatment. We also
analysed a strain disrupted for DDC1, a gene that acts
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Figure 3
A single chromosomal DNA DSB triggers Sir3p relocation and
disruption of telomeric silencing. (a) Wild-type (WT, W303) cells were
transformed with pRS416 or pGAL:HO. Cells from each
transformation were grown in SC–URA medium containing 2%
galactose overnight before fixing and staining with anti-Sir3p antibody
(upper panels) and DAPI (lower panels). Insets show cells from the
same population. (b) Western blotting with anti-Sir3p or anti-tubulin
antibodies was performed using equal amounts of whole-cell extract
from wild-type cells containing either pRS416 or pGAL:HO and grown
in galactose. (c) Strain TEL::ADE2 was transformed with empty vector
or with the plasmid expressing HO endonuclease, and a colony from
each transformation was plated onto YP medium containing galactose
to assess colony colour and thereby telomeric silencing.
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genetically together with or upstream of MEC1 [13]. The
ddc1 mutant strain had the same phenotype as the MEC1-
disrupted strain, in that it failed to induce diffuse Sir3p
staining following bleomycin treatment (Figure 4).  
The role of Sir3p in the response to DNA damage
These data suggest that a pathway dependent on Mec1p
and Ddc1p triggers the release of Sir3p from the telomere
following DNA damage. Consistent with this idea, while
this paper was in revision, two other groups reported
similar findings that Sir proteins and Ku relocate in yeast
after DNA damage, associate with sites of DNA DSBs and
appear to play a role in NHEJ independent of mating-type
status [14,15]. It is tempting to speculate that release of
Sir3p from telomeres is mediated by modulating the inter-
actions between Sir3p and telomere-targeting factors such
as Yku70p/Yku80p and/or Rap1p. Release of Sir proteins
and Ku may allow their direct participation in DNA DSB
repair. Alternatively, or in addition, Sir protein relocation
could induce changes in chromatin structure to bring
about coordinated transcriptional responses to DNA
damage. Sir protein relocation may also serve to shut-
down temporarily and stabilise essential nuclear processes,
such as DNA replication and transcription, while the
repair of potentially lethal DNA damage takes place. In
this way, Sir proteins could contribute to genomic stability
by multiple mechanisms.
Supplementary material
Additional data, methodological details and yeast genotypes are avail-
able at http://current-biology.com/supmat/supmatin.htm.
Acknowledgements
We thank D. Shore and G. Cuperius for yeast strains; D. Moazed for anti-
Sir3p antibodies; J. Downs for strain JDY1; S. Buratowski for the pGAL:HO
plasmid; and all members of the S.P.J. lab for their advice and support,
especially D. Durocher, J. Rouse and C. Featherstone. This work was
funded by grants from The Cancer Research Campaign and the BBSRC.
A.M. is supported by a studentship from the Medical Research Council, UK.
References
1. Weinert T: DNA damage and checkpoint pathways: molecular
anatomy and interactions with repair. Cell 1998, 94:555-558.
2. Sandell LL, Zakian VA: Loss of a yeast telomere: arrest, recovery,
and chromosome loss. Cell 1993, 75:729-739.
3. Critchlow SE, Jackson SP: DNA end joining: from yeast to man.
Trends Biochem Sci 1998, 23:394-398.
4. Tsukamoto Y, Kato J, Ikeda H: Silencing factors participate in DNA
repair and recombination in Saccharomyces cerevisiae. Nature
1997, 388:900-903.
5. Boulton SJ, Jackson SP: Components of the Ku-dependent
non-homologous end-joining pathway are involved in telomeric
length maintenance and telomeric silencing. EMBO J 1998,
17:1819-1828.
6. Grunstein M: Molecular model for telomeric heterochromatin in
yeast. Curr Opin Cell Biol 1997, 9:383-387.
7. Povirk LF: DNA damage and mutagenesis by radiomimetic
DNA-cleaving agents: bleomycin, neocarzinostatin and other
enediynes. Mutat Res 1996, 355:71-89.
8. Ahne F, Jha B, Eckardt-Schupp F: The RAD5 gene product is
involved in the avoidance of non-homologous end-joining of DNA
double strand breaks in the yeast Saccharomyces cerevisiae.
Nucleic Acids Res 1997, 25:743-749.
9. Palladino F, Laroche T, Gilson E, Axelrod A, Pillus L, Gasser SM: SIR3
and SIR4 are required for the positioning and integrity of yeast
telomeres. Cell 1993, 75:543-555.
10. Scott-Drew S, Murray JAH: Localisation and interaction of the
protein components of the yeast 2µ circle plasmid-partitioning
system suggest a mechanism for plasmid inheritance. J Cell Sci
1998, 111:1779-1789.
11. Sanchez Y, Desany BA, Jones WJ, Liu QH, Wang B, Elledge SJ:
Regulation of Rad53 by the ATM-like kinases Mec1 and Tel1 in
yeast cell cycle checkpoint pathways. Science 1996, 271:357-360.
12. de la Torre-Ruiz MA, Green CM, Lowndes NF: RAD9 and RAD24
define two additive, interacting branches of the DNA damage
checkpoint pathway in budding yeast normally required for Rad53
modification and activation. EMBO J 1998, 17:2687-2698.
13. Longhese MP, Paciotti V, Fraschini R, Zaccarini R, Plevani P, Lucchini
G: The novel DNA damage checkpoint protein Ddc1p is
phosphorylated periodically during the cell cycle and in response
to DNA damage in budding yeast. EMBO J 1997, 16:5216-5226.
14. Martin SG, Laroche T, Suka N, Grunstein M, Gasser SM:
Relocalization of telomeric Ku and Sir proteins in response to
DNA strand breaks in yeast. Cell 1999, 97:621-633.
15. Mills KD, Sinclair DA, Guarente L: MEC1-dependent redistribution
of the Sir3 silencing protein from telomeres to DNA double-
strand breaks. Cell 1999, 97:609-620.
966 Current Biology, Vol 9 No 17
Figure 4
DNA-damage checkpoint-signalling components are crucial for Sir3p
relocation. Untreated or bleomycin-treated strains were stained with
anti-Sir3p antibody or DAPI, as indicated. Strains used were wild-type
strain W303; ∆mec1 strain U953-61A; ∆tel1 strain Y654; ∆rad53
strain U960-5C; and ∆ddc1 strain YLL244.
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Supplementary materials and methods
Yeast strains, media and plasmids
Yeast strains used in this study are described in Table S1. Non-selec-
tive medium (YP) and selective media (SC) were prepared as
described previously [S1]. Medium containing 5-FOA, with or without
bleomycin, was prepared as follows. Bleomycin (Kyowa) was resus-
pended in sterile water to a concentration of 10 mg/ml. The appropri-
ate amount of bleomycin was added to 7.5 ml aliquots of solution A
(10 µg/ml uracil with or without 0.1% 5-FOA; Melford laboratories) and
stored at 4°C. Solution B (0.67% yeast nitrogen base –AA/AS, 2%
dextrose, 2% agar and 20 mg/ml of each tryptophan, lysine, histidine
and leucine) containing 0.8 mg/ml amino-acid drop-out mix was auto-
claved and allowed to cool to 55°C. Solution B (7.5 ml) was then
added to 7.5 ml solution A at room temperature, mixed gently and
poured into Petri dishes. Plates were dried, stored at room temperature
and used within 24 h.
Silencing assays
Assays for silencing using the TEL::URA3 reporter were carried out by
inoculating a single colony into 10 ml liquid YPD or the appropriate
synthetic (SC) selective medium and incubating overnight at 30°C. The
next day, the culture was diluted to a density of 1 × 107 cells per ml in
sterile water, and 7.5 µl aliquots of 10-fold serial dilutions were spotted
onto the appropriate selective medium as described above. Plates
were incubated at 30°C for 3–4 days before the strength of silencing
was assessed. For the TEL::ADE2 reporter, single red colonies were
streaked onto YPD containing the appropriate concentration of
bleomycin, then incubated for 3 days before placing at 4°C for
1–2 weeks to allow pigment accumulation.
Protein extracts and immunoblotting
Whole-cell protein extract (WCE) was made as described previously
[S2]. WCE (50 µg) was separated on SDS–7% polyacrylamide gels,
transferred onto nitrocellulose membrane and probed with the anti-
Sir3p polyclonal antibody (1:5000), followed by incubation with a
horseradish-peroxidase-conjugated goat anti-rabbit secondary antibody
(Pierce). Detection was performed using the Amersham enhanced
chemiluminescence (ECL) system. Membranes were stripped and
reprobed with an anti-tubulin polyclonal antibody (Sera Labs), incu-
bated with a horseradish-peroxidase-conjugated anti-rat secondary
antibody (Sera Labs) and detected using ECL. 
Indirect immunofluorescence
Cultures of the appropriate strain were grown from a single colony in
10 ml YPD overnight at 30°C. The culture was then diluted to 1 × 107
cells per ml in 20 ml fresh YPD and grown at 30°C for a further 2 h. At
this point, the culture was split into two 10 ml samples, and freshly pre-
pared bleomycin was added to one of the cultures to a final concentra-
tion of 20 µg/ml. Both cultures were then incubated for a further 2 h at
30°C before fixing the cells in 3.7% formaldehyde and processing
them for immunofluorescence microscopy as described previously
[S3]. Anti-Sir3p antibody binding was detected with an anti-rabbit
FITC-conjugated secondary antibody (Amersham). Anti-Rep1p and
anti-tubulin (Sera Labs) antibodies were used as described previously
[S3]. Slides were mounted in Vectashield containing DAPI (Vector lab-
oratories), visualised using a Nikon Optishot-2 fluorescence micro-
scope, and photographed at the same exposure with Fujichrome provia
1600 asa slide film. Images were scanned using Nikon CoolScan and
assembled using Adobe Photoshop 4.
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Table S1
Yeast strains used in this study.
Strain Genotype Constructed by
W303 MATα ade2 his3 leu2 trp1 [S4]
ura3 can1-100
TEL::ADE2 W303 MATα TELadh4::ADE2 G. Cuperius
YP4 W303 MATa TELadh4::URA3 D. Shore
JDY1 W303 MATα rad52::TRP1 J. Downs
U953-61A W303 MATa mec1::TRP1 [S5]
sml1::HIS3
U960-5C W303 MATa rad53::HIS3 [S5]
sml1-1
UCC3 JRY1264 MATα his3 trp1 D. Gottschling
ura3-52 sir3::LYS2
TELadh4::URA3
YLL244 MATa ade2-1 trp1-1leu2-3, [S6]
112 his3-11,15 ura3 can1-100
ddc1::KanMX4
Y654 Y323 MATa tel1::HIS3 [S7]
